EUR 110.2
(-1.25%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 1.98 EUR | -49.36% |
2022 | 3.91 EUR | -54.22% |
2021 | 8.54 EUR | 45.98% |
2020 | 5.85 EUR | 150100.0% |
2019 | -0.00 EUR | -100.06% |
2018 | 6.41 EUR | -0.16% |
2017 | 6.42 EUR | 57.74% |
2016 | 4.07 EUR | -14.68% |
2015 | 4.77 EUR | 250.74% |
2014 | 1.36 EUR | -1.45% |
2013 | 1.38 EUR | -20.69% |
2012 | 1.74 EUR | 20.0% |
2011 | 1.45 EUR | 208.51% |
2010 | 0.47 EUR | -87.16% |
2009 | 3.66 EUR | 18129.56% |
2008 | -0.02 EUR | -102.28% |
2007 | 0.89 EUR | -91.68% |
2006 | 10.70 EUR | 62.37% |
2005 | 6.59 EUR | 142.28% |
2004 | 2.72 EUR | -26.29% |
2003 | 3.69 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 2.09 EUR | 0.0% |
2023 Q4 | -0.07 EUR | 0.0% |
2023 Q2 | 2.05 EUR | 0.0% |
2023 FY | - EUR | -49.36% |
2022 FY | - EUR | -54.22% |
2022 Q2 | 3.25 EUR | 0.0% |
2022 Q4 | -1.33 EUR | 0.0% |
2021 Q2 | 4.60 EUR | 0.0% |
2021 FY | - EUR | 45.98% |
2021 Q4 | 3.94 EUR | 0.0% |
2020 Q4 | 2.94 EUR | 0.0% |
2020 FY | - EUR | 150100.0% |
2020 Q2 | 2.91 EUR | 0.0% |
2019 FY | - EUR | -100.06% |
2019 Q2 | 3.31 EUR | 0.0% |
2019 Q4 | 1.00 EUR | 0.0% |
2018 FY | - EUR | -0.16% |
2018 Q1 | 3.22 EUR | 8.78% |
2018 Q4 | 1.97 EUR | 0.0% |
2018 Q2 | 4.43 EUR | 37.58% |
2017 Q2 | 3.46 EUR | 116.25% |
2017 FY | - EUR | 57.74% |
2017 Q4 | 2.96 EUR | 0.0% |
2017 Q1 | 1.60 EUR | -4.76% |
2016 FY | - EUR | -14.68% |
2016 Q4 | 1.68 EUR | 0.0% |
2016 Q2 | 2.39 EUR | 134.31% |
2016 Q1 | 1.02 EUR | -63.04% |
2015 FY | - EUR | 250.74% |
2015 Q3 | 1.19 EUR | -40.8% |
2015 Q4 | 2.76 EUR | 131.93% |
2015 Q2 | 2.01 EUR | 68.91% |
2015 Q1 | 1.19 EUR | 176.74% |
2014 Q4 | 0.43 EUR | 26.47% |
2014 FY | - EUR | -1.45% |
2014 Q3 | 0.34 EUR | -63.44% |
2014 Q1 | 0.34 EUR | -48.48% |
2014 Q2 | 0.93 EUR | 173.53% |
2013 Q2 | 0.33 EUR | -5.71% |
2013 Q1 | 0.35 EUR | 0.0% |
2013 Q4 | 0.66 EUR | 88.57% |
2013 Q3 | 0.35 EUR | 6.06% |
2013 FY | - EUR | -20.69% |
2012 Q1 | 0.44 EUR | 0.0% |
2012 FY | - EUR | 20.0% |
2012 Q3 | 0.44 EUR | 0.0% |
2012 Q4 | 0.35 EUR | -20.45% |
2012 Q2 | 0.44 EUR | 0.0% |
2011 Q3 | 0.36 EUR | 0.0% |
2011 FY | - EUR | 208.51% |
2011 Q4 | 0.44 EUR | 22.22% |
2011 Q2 | 0.36 EUR | 0.0% |
2011 Q1 | 0.36 EUR | 0.0% |
2010 Q4 | 0.36 EUR | 200.0% |
2010 Q1 | 0.12 EUR | 0.0% |
2010 FY | - EUR | -87.16% |
2010 Q3 | 0.12 EUR | 0.0% |
2010 Q2 | 0.12 EUR | 0.0% |
2009 Q4 | 0.12 EUR | -86.96% |
2009 Q1 | 0.92 EUR | 0.0% |
2009 Q2 | 0.92 EUR | 0.0% |
2009 FY | - EUR | 18129.56% |
2009 Q3 | 0.92 EUR | 0.0% |
2008 Q1 | -0.01 EUR | 0.0% |
2008 Q3 | -0.01 EUR | 0.0% |
2008 Q2 | -0.01 EUR | 0.0% |
2008 Q4 | 0.92 EUR | 18139.22% |
2008 FY | - EUR | -102.28% |
2007 Q2 | 0.22 EUR | 0.0% |
2007 Q4 | -0.01 EUR | -102.32% |
2007 Q1 | 0.22 EUR | 0.0% |
2007 Q3 | 0.22 EUR | 0.0% |
2007 FY | - EUR | -91.68% |
2006 Q1 | 2.67 EUR | 0.0% |
2006 Q2 | 2.67 EUR | 0.0% |
2006 Q3 | 2.67 EUR | 0.0% |
2006 Q4 | 0.22 EUR | -91.76% |
2006 FY | - EUR | 62.37% |
2005 FY | - EUR | 142.28% |
2005 Q4 | 2.67 EUR | 61.82% |
2005 Q3 | 1.65 EUR | 0.0% |
2005 Q2 | 1.65 EUR | 0.0% |
2005 Q1 | 1.65 EUR | 0.0% |
2004 Q4 | 1.65 EUR | 142.65% |
2004 Q2 | 0.68 EUR | 0.0% |
2004 Q3 | 0.68 EUR | 0.0% |
2004 Q1 | 0.68 EUR | 0.0% |
2004 FY | - EUR | -26.29% |
2003 Q3 | 0.92 EUR | 0.0% |
2003 FY | - EUR | 0.0% |
2003 Q2 | 0.92 EUR | 0.0% |
2003 Q1 | 0.92 EUR | 0.0% |
2003 Q4 | 0.68 EUR | -26.09% |
2002 Q4 | 0.92 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Nicox S.A. | -0.42 EUR | 571.429% |
European Medical Solutions | -0.00 EUR | 396100.0% |
FERMENTALG | -0.32 EUR | 718.75% |
argenx SE | -4.67 EUR | 142.398% |
BioSenic S.A. | -0.21 EUR | 1042.857% |
Celyad Oncology SA | -0.33 EUR | 700.0% |
Hyloris Pharmaceuticals SA | -0.55 EUR | 460.0% |
Onward Medical N.V. | -1.20 EUR | 265.0% |
Oxurion NV | -0.01 EUR | 17317.391% |
PHAXIAM Therapeutics S.A. | -5.00 EUR | 139.6% |
UCB SA | 1.81 EUR | -9.392% |